Study details
Enrolling now
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
Northwestern University
NCT IDNCT05990426ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 2.9 years
Ages
18+
Sex
Female only
Locations
1 site in IL
About this study
Researchers are testing whether alternate day fasting can help reduce side effects during chemotherapy treatment for endometrial, ovarian, and uterine cancers. The trial is testing a behavioral intervention called FAST.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in FAST Intervention
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Adverse events and toxicity, Neuropathic Pain, Physical Function
Body systems
Oncology